FITC-labeled Agatolimod (sodium), a class B CpG ODN (oligodeoxynucleotide) and TLR9 agonist, enables the evaluation of CpG ODN cellular uptake and localization using confocal laser-scanning microscopy (excitation 495 nm, emission 520 nm) or flow cytometry.